论文信息 - Randomized phase 2 study of abiraterone acetate (AA) with or without exemestane (E) in postmenopausal patients (pts) with estrogen receptor–positive (ER+) metastatic breast cancer (MBC). - 字舞流文

Randomized phase 2 study of abiraterone acetate (AA) with or without exemestane (E) in postmenopausal patients (pts) with estrogen receptor–positive (ER+) metastatic breast cancer (MBC).

P. Neven | M. Campone | D. Hayes | S. Johnston | I. Bondarenko | J. O’Shaughnessy | E. Brain | T. Griffin | Margaret K Yu | T. Kheoh | W. Peng | P. Porre | Jason L. Martin | Jason L. Martin